Carton (Carton)
Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 60505-6271
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 60505-6271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Figure 1)
The given text appears to be a result summary from a medical study or clinical trial. It includes information about the Log-Rank p-value, hazard ratio (HR), and number of deaths. However, without further context or additional information, it is difficult to provide a more specific description.*
Structure (Structure)
Flat Label (Flat Label)
NDC 60505-6271-1 is an Azacitidine medication for injection. Each vial contains 100 mg of Azacitidine and mannitol. It is intended for subcutaneous and intravenous use only. The medication is a cytotoxic agent, meaning it is used to kill cancer cells. The recommended dosage and administration should be followed as per the prescribing information. Any unused portion of the single-dose vial should be discarded. The medication should be stored at a controlled room temperature between 15°C to 30°C (59°F to 86°F). It is manufactured by Jiangsu Hansoh Pharmaceutical Group Co., Ltd., China and distributed by Apotex Corp., Weston Florida, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
